Keisuke Miyazawa, Shin Aizawa. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Adenoviridae/geneticsAnemia/chemically inducedAnemia/drug therapyAntifibrinolytic Agents/pharmacologyAntigens, CD34/biosynthesisBone Marrow Cells/cytologyCoculture TechniquesDose-Response Relationship, DrugEndothelial Cells/cytologyEnzyme-Linked Immunosorbent AssayHematologic Diseases/drug therapyHematopoietic Stem Cells/cytologyHumansStromal Cells/cytologyTime FactorsTumor Necrosis Factor-alpha/biosynthesisVitamin K 2/adverse effectsVitamin K 2/metabolismVitamin K 2/pharmacology
Substances: See more » Antifibrinolytic AgentsAntigens, CD34Tumor Necrosis Factor-alphaVitamin K 2
Year: 2004 PMID: 15588500 DOI: 10.1089/scd.2004.13.449
Source DB: PubMed Journal: Stem Cells Dev ISSN: 1547-3287 Impact factor: 3.272